StockData
RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

VIVOS INC

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$0.05−0.00 (-2.51%)

Close on Oct 19, 2026

Market cap
$23.44M
P/E (TTM)
–
Dividend yield
–

VIVOS INC revenue by segment

By business segment

By product or service

RevenueTTM Q2 26TTM Q1 26TTM Q4 25TTM Q3 25TTM Q2 25TTM Q1 25TTM Q4 24% of revenueYoY
IsoPet [Member]$286.44K$214.01K$143.03K––––289.0%–
Freight [Member]$4.55K$3.15K$1.05K––––4.6%–
Polymer [Member]$4.22K–$1.06K––––4.3%–
Discount - Services [Member]––-$71.82K-$71.82K-$69.67K-$59.44K-$2.00K––
Services - Treatments [Member]––$88.88K$93.87K$95.72K$89.69K$30.00K––
Discount - Certifications [Member]––-$10.00K––––––
Certification [Member]––$37.48K––––––

By region

From the segment and revenue-disaggregation notes of Vivos's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.